Intraoperative MRI Equipment Market Analysis and Forecast by Fact.MR
- The Intraoperative MRI Equipment Market is expected to grow from USD 1.3 billion in 2026 to USD 2.9 billion by 2036, at an 8.5% CAGR.
- Driven by growing neurosurgical demand for real-time intraoperative imaging to maximize tumor resection and preserve neurological function, expanding surgical suite installations in academic medical centers, and advancing integration between MRI systems and surgical navigation platforms, with high field systems accounting for 44.8% share.
- Image-guided navigation systems contributing 41.3% share as hospitals invest in hybrid operating room infrastructure and AI-assisted surgical planning capabilities.

Summary of Intraoperative MRI Equipment Market
- Market Snapshot
- In 2025, the global Intraoperative MRI Equipment Market was valued at approximately USD 1.2 billion.
- The market is estimated to reach USD 1.3 billion in 2026 and is projected to attain USD 2.9 billion by 2036.
- The intraoperative MRI equipment market is likely to expand at a CAGR of 8.5% during the forecast period.
- The market is anticipated to create an absolute dollar opportunity of USD 1.6 billion between 2026 and 2036.
- High field intraoperative MRI systems account for 44.8% of product segment share in 2026.
- China (8.6%) and U.S. (8.1%) are the key growth markets during the forecast period.
- Demand and Growth Drivers
- Neurosurgical demand for real-time imaging during glioma resection to maximize extent of resection while preserving eloquent cortex function is the primary growth driver.
- Growing clinical evidence demonstrating improved patient outcomes and reduced reoperation rates with intraoperative MRI guidance is supporting hospital capital investment.
- Hybrid operating room construction in academic medical centers and tertiary hospitals is creating new installation sites for integrated intraoperative MRI systems.
- Integration of MRI with surgical navigation, neuromonitoring, and robotic-assisted surgery platforms is expanding the clinical utility of intraoperative imaging.
- The addressable market is being expanded as applications are being extended from neurosurgery to musculoskeletal, cardiovascular and interventional radiology procedures.
- Product and Segment View
- High field intraoperative MRI systems lead with 44.8 % of product share in 2026 providing better image resolution for neurosurgical tumor margin assessment.
- 41.3% technology integration share of image-guided navigation systems indicates the importance of surgical navigation in intraoperative MRI workflows.
- Key segmentation includes:
- Product High Field Intraoperative MRI Systems Mid Field Intraoperative MRI Systems Low Field Intraoperative MRI Systems
- Applications: Neurosurgery Applications, Orthopedic Applications, Cardiovascular Applications, Interventional Radiology Applications
- Configuration MRI Open Configuration MRI Movable Configuration MRI Bore Configuration
- These systems enable:
- Real-time surgical decision-making using real-time anatomical imaging in active procedures
- Compensation of brain shift for intraoperative tissue displacement in tumor resection
- Real-time confirmation of surgical results prior to closing wounds, lowering the incidence of reoperations
- Geography and Competitive Outlook
- Asia Pacific is the growth leader with China growing at 8.6% CAGR driven by expansion of hospitals and growth in neurosurgery centers and government investment in advanced medical imaging.
- North America (8.1%) (U.S.) shows strong academic medical center investment, FDA regulatory pathways and established neurosurgical demand.
- Europe is exhibiting steady growth, with Germany at 7.2%, aided by sophisticated university hospital networks, and the UK at 6.8%, bolstered by investment in NHS neuroscience centres.
- Major Players are General Electric Company, Siemens AG, Medtronic Plc, Koninklijke Philips N.V., Hitachi Ltd./Toshiba Corporation, IMRIS Inc.
- Analyst Opinion
- Shambhu Nath Jha, Principal Consultant at Fact.MR, says "The intraoperative MRI equipment market is concentrated in a small number of high-value installations, primarily in academic neurosurgery centers where the clinical evidence for improved tumor resection outcomes justifies the substantial capital investment. GE and Siemens dominate because they control the MRI magnet technology and can integrate imaging with the surgical navigation and workflow systems that neurosurgeons require. The growth opportunity is expanding as movable MRI configurations reduce the infrastructure burden of dedicated intraoperative suites, making the technology accessible to hospitals that cannot justify a permanent integrated operating room."
Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth
- Clinical evidence demonstrating that intraoperative MRI-guided glioma resection improves extent of resection and progression-free survival is strengthening the investment case for hospital procurement.
- Hybrid operating room construction programs in academic and tertiary hospitals are creating dedicated infrastructure for intraoperative MRI integration.
- Surgical navigation platform integration with intraoperative MRI is expanding clinical utility by enabling real-time brain shift compensation and updated trajectory planning.
Key Market Constraints
- High capital costs (typically >USD 5 million per installation including room shielding and MRI-compatible surgical instrumentation) limit adoption to well-funded institutions.
- The need for intraoperative imaging increases the procedure time, which lowers the surgical throughput and leads to problems with operating room scheduling.
- MRI-compatible surgical instrument requirements include ongoing consumable and equipment costs beyond the initial system installation.
Key Opportunity Areas
- Configurable intraoperative MRI that is shared between multiple operating rooms reduce capital outlay per room and increase the number of hospital sites that can be served.
- Automated tumor boundary detection and AI-assisted image analysis are reducing the burden of interpretation for surgeons and improving workflow efficiency.
- The clinical justification for capital investment is expanding beyond neurosurgery, with the clinical applications in spine, musculoskeletal and interventional procedures also expanding.
Segment-wise Analysis of the Intraoperative MRI Equipment Market
- High field intraoperative MRI systems are expected to account for 44.8% product share in 2026. This is due to improved image resolution required to evaluate tumor margins in neurosurgery.
- Neurosurgical applications represent the largest share of 46.2% due to the clinical origin and strongest evidence base for the use of intraoperative MRI.
- Image-guided navigation systems have a technology integration share of 41.3% and it is attributed to the critical role of navigation in MRI-guided surgical workflows.
The market has been segmented on the basis of product, magnetic field strength, application, configuration, technology integration and region. High field systems (1.5T and 3T) are the best quality for imaging in neurosurgical applications. Mid and low field systems are used for cost sensitive installations and non-neurosurgical applications.
Which Product Segment Dominates the Intraoperative MRI Equipment Market?

High field intraoperative MRI systems account for 44.8% of product segment value in 2026. 1.5T and 3T systems deliver the image resolution neurosurgeons require to distinguish tumor margins from healthy brain tissue during active resection. The 3T configuration is gaining share in academic centers where advanced functional imaging and diffusion tensor tractography are used for real-time white matter tract visualization.
Mid field and low field systems serve installations where cost, space, or procedure type requirements do not justify high field investment. These systems are more common in musculoskeletal and interventional applications where ultra-high image resolution is less critical.
Which Application Segment Dominates the Intraoperative MRI Equipment Market?

Neurosurgery applications account for 46.2% of application segment value in 2026. Brain tumor resection, particularly glioma surgery, is the clinical application with the strongest evidence base for intraoperative MRI utilization. The ability to image brain shift and updated tumor boundaries during surgery directly influences resection completeness and patient outcomes.
Orthopedic and spine applications are growing as intraoperative MRI is adopted for intervertebral disc procedures and spinal tumor resection. Cardiovascular applications remain nascent but are advancing through MRI-guided catheter ablation and structural heart intervention research.
Which Product Trend is Shaping the Next Phase of Growth in the Intraoperative MRI Equipment Market?
The top product trend expanding the addressable market is the emergence of movable high field MRI configurations that can be moved from one operating room to another. Standard intraoperative MRI systems require dedicated, permanently shielded operating rooms. These are large capital investments. Systems that move on ceiling rails or mobile platforms enable a single MRI to serve multiple operating rooms, increasing utilization rates and decreasing capital allocation per procedure.
Companies such as Medtronic, which offers its Stealth AXiS Surgical System that integrates navigation with intraoperative imaging workflows, support this configuration shift. The availability of mobile MRI combined with AI-assisted image analysis is expanding intraoperative imaging to community neurosurgery programs that have lower case volumes than academic centers.
Regional Outlook Across Key Markets
- No. 1 is China at 8.6%, helped by construction of hospital neurosurgery centers, government investment in advanced medical imaging and growing domestic MRI manufacturing capability.
- The U.S. at 8.1% shows a healthy capital investment in academic medical centers, a well-established neurosurgical demand, and regulatory support from the FDA for image-guided surgery systems.
- European markets are still growing steadily with Germany at 7.2% driven by university hospital networks and UK at 6.8% driven by NHS neuroscience service investment.
.webp)
CAGR Table
| Country |
CAGR (%) |
| China |
8.6% |
| USA |
8.1% |
| South Korea |
7.4% |
| Germany |
7.2% |
| Japan |
6.9% |
| UK |
6.8% |
| France |
6.5% |
| Italy |
6.3% |
Source: Fact.MR analysis, based on proprietary forecasting model and primary research.

Market Outlook for Intraoperative MRI Equipment in China
The China Intraoperative MRI Equipment Market is projected to grow at a CAGR of 8.6% through 2036. Hospital neurosurgery center expansion and government investment in advanced medical imaging infrastructure are creating new installation opportunities. Technology self-sufficiency policies support domestic MRI component development to reduce import dependency.
- Tier-1 city academic hospitals are installing high field intraoperative MRI suites to support advanced neurosurgical programs.
- Domestic MRI manufacturers are developing mid-field intraoperative systems targeting price-sensitive hospital installations.
- Government healthcare investment programs are expanding neurosurgery capacity in provincial medical centers beyond traditional coastal city concentration.
U.S. Intraoperative MRI Equipment Demand Trends

The U.S. Intraoperative MRI Equipment Market is projected to grow at a CAGR of 8.1% through 2036. FDA regulatory pathways support timely market access for image-guided surgery systems. Insurance reimbursement for MRI-guided neurosurgical procedures and hospital capital budget cycles influence procurement timing.
- Academic medical center capital programs are the primary installation channel for high field intraoperative MRI systems.
- Medicare reimbursement for neurosurgical procedures using intraoperative imaging supports institutional ROI justification for capital investment.
- Hospital system consolidation concentrates imaging capital decisions across multi-site health networks.
Germany Intraoperative MRI Equipment Market Growth Assessment
The Germany Intraoperative MRI Equipment Market is projected to grow at a CAGR of 7.2% through 2036. EU MDR/IVDR compliance standards shape medical imaging device qualification timelines. Advanced university hospital networks with established neurosurgery programs create concentrated demand for high field intraoperative MRI installations.
- University hospital neurosurgery departments are the primary end users, with multiple installations already operational across leading German academic centers.
- GKV reimbursement frameworks for advanced neurosurgical procedures support the clinical adoption case for intraoperative MRI-guided surgery.
- Industrie 4.0 integration concepts are influencing hybrid operating room design and digital imaging workflow optimization.
UK Intraoperative MRI Equipment Market Growth Outlook
The UK Intraoperative MRI Equipment Market is projected to grow at a CAGR of 6.8% through 2036. NICE health technology assessments guide NHS procurement decisions for high-value imaging equipment. NHS neuroscience center investment programs are expanding intraoperative MRI access beyond the small number of existing installations.
- NHS capital investment programs for neuroscience centers are creating new installation opportunities for intraoperative MRI systems.
- NICE evidence evaluation supports clinical adoption by providing independent assessment of intraoperative MRI cost-effectiveness.
- Post-Brexit MHRA regulatory requirements create separate device approval timelines from EU CE marking processes for imaging systems.
Japan Intraoperative MRI Equipment Market Demand Analysis

The Japan Intraoperative MRI Equipment Market is projected to grow at a CAGR of 6.9% through 2036. PMDA device approval pathways and NHI reimbursement considerations influence equipment procurement cycles. The aging population increases brain tumor incidence, expanding the clinical demand for MRI-guided neurosurgical procedures.
- Aging demographics increase glioma and meningioma incidence, sustaining neurosurgical demand for intraoperative imaging.
- Domestic OEM presence through Hitachi and Toshiba (Canon Medical) supports local installation, service, and training infrastructure.
- Long device qualification cycles and domestic preference influence procurement timelines for imported intraoperative MRI systems.
Competitive Benchmarking and Company Positioning

Intraoperative MRI Equipment Market Analysis By Company
- General Electric Company leads with approximately 27.0% market share through its SIGNA MRI platform and established relationships with major neurosurgery centers, supported by global installation, service, and upgrade capabilities.
- Siemens AG competes through its Nexaris and MAGNETOM intraoperative MRI platforms, offering integrated workflows combining MRI with angiography and surgical navigation in hybrid operating environments.
- Medtronic differentiates through surgical navigation integration, connecting its Stealth navigation platform with intraoperative imaging to provide neurosurgeons with real-time image-guided surgical workflows.
The competitive landscape is highly concentrated, with GE and Siemens controlling the majority of installed systems through their dominance in MRI magnet technology and hospital imaging relationships. Philips maintains a presence through its Ingenia and Ambition MRI platforms adapted for intraoperative configurations.
Medtronic occupies a distinctive position as the leading surgical navigation company, connecting imaging with surgical workflow through its Stealth AXiS platform. IMRIS (now part of Deerfield Imaging) pioneered the movable intraoperative MRI concept, and its installed base continues to generate service and upgrade revenue.
Key Companies in the Intraoperative MRI Equipment Market
- General Electric Company, Siemens AG, Medtronic Plc, Koninklijke Philips N.V., Hitachi Ltd./Toshiba Corporation, and IMRIS Inc. are the leading companies in the intraoperative MRI equipment market.
Recent Industry Developments
IMRIS receives FDA 510(k) clearance for InVision™ 1.5 Surgical Theatre (2024)
- IMRIS (Deerfield Imaging) received FDA 510(k) clearance for its InVision 1.5 Surgical Theatre, a ceiling-mounted intraoperative MRI system designed for real-time imaging during neurosurgical procedures.
IMRIS acquired by Grovecourt Capital Partners (2025)
- Grovecourt Capital Partners, a private equity firm based in Florida, announced the acquisition of IMRIS Imaging, Inc., a global leader in intraoperative MRI (iMRI) operating suites used in neurosurgery and oncology procedures.
Leading Companies Shaping the Intraoperative MRI Equipment Market
- General Electric Company
- Siemens AG
- Medtronic Plc
- Koninklijke Philips N.V.
- Brainlab AG
- Canon Medical Systems
- Stryker Corporation
Sources and Research References
- IMRIS, Deerfield Imaging, Inc. (2024). IMRIS receives FDA clearance for the InVision™ 1.5 Surgical Theatre.
- Grovecourt Capital Partners. (2025). Grovecourt Capital Partners announces acquisition of IMRIS.
This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.
Key Questions This Report Addresses
- What is the estimated size of the global Intraoperative MRI Equipment Market in 2026, and how is it projected to grow through the 2026 to 2036 forecast period?
- What incremental revenue opportunity is the Intraoperative MRI Equipment Market expected to create between 2026 and 2036, and what CAGR underpins this projection?
- Which product segment holds the largest share in 2026, and what clinical performance factors support high field intraoperative MRI system leadership?
- How is the balance between high field and mid/low field intraoperative MRI systems expected to shift as movable configurations expand the addressable market?
- Which application segment is projected to generate the most incremental revenue through 2036, and what clinical evidence supports neurosurgery demand leadership?
- Which countries are projected to register the highest CAGR through 2036, and what hospital infrastructure investments accelerate their growth?
- How do demand patterns in China compare with those in the U.S. and Europe in terms of installation base, capital investment, and clinical adoption maturity?
- What capital cost and operational constraints could limit intraoperative MRI adoption rates beyond academic medical centers during the forecast period?
- What are the primary demand-side drivers sustaining growth, and how do they vary between neurosurgery and emerging non-neurosurgical applications?
- Who are the leading companies, and how are they differentiating through MRI technology, navigation integration, and hybrid operating room solutions?
- What recent regulatory clearances and product developments in 2025 are reshaping competitive positioning in the intraoperative MRI market?
- Which product configuration or integration trend is driving the next phase of growth, and how are movable MRI systems changing hospital adoption economics?
- How is AI-assisted image analysis and automated tumor boundary detection influencing surgical workflows and intraoperative MRI utilization patterns?
- What role are reimbursement frameworks, clinical outcome evidence, and hybrid OR construction programs playing in reshaping hospital capital investment decisions?
Intraoperative MRI Equipment Market Definition
The intraoperative MRI equipment market covers magnetic resonance imaging systems designed for use during active surgical procedures to provide real-time anatomical imaging. It includes high, mid, and low field systems in open, bore, and movable configurations used across neurosurgery, orthopedic, cardiovascular, and interventional radiology applications.
Intraoperative MRI Equipment Market Inclusions
- Global and regional market size and forecasts for 2026 to 2036 across product, magnetic field strength, application, configuration, technology integration, and region.
- Demand analysis based on neurosurgical procedure volumes, hybrid operating room installations, hospital capital expenditure trends, and clinical outcome evidence.
- Competitive landscape including system portfolios, integration capabilities, and service contract strategies of leading OEMs.
Intraoperative MRI Equipment Market Exclusions
- Diagnostic MRI systems used in radiology departments without intraoperative surgical integration capabilities.
- Intraoperative CT, ultrasound, and fluoroscopy systems that do not utilize magnetic resonance imaging technology.
- Standalone surgical navigation systems sold without integrated MRI components or MRI-compatible configurations.
Intraoperative MRI Equipment Market Research Methodology
- Methodology combines secondary research from neurosurgical journals, hospital capital equipment databases, and medical imaging OEM publications with primary validation.
- Market sizing covers 30+ countries with inputs including neurosurgery center density, hybrid OR installations, hospital capital budgets, and clinical evidence adoption rates.
- Primary validation includes 18+ interviews across neurosurgeons, hospital radiology directors, imaging OEM representatives, and healthcare capital planning teams.